» Authors » Emilio Maseda

Emilio Maseda

Explore the profile of Emilio Maseda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 67
Citations 631
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
de la Fuente A, Lopez-Sanchez J, Vaquero-Roncero L, Merino Garcia M, Sanchez Barrado M, Sanchez-Hernandez M, et al.
Int J Infect Dis . 2024 Jun; 146:107142. PMID: 38901729
Objectives: Identifying host response biomarkers implicated in the emergence of organ failure during infection is key to improving the early detection of this complication. Methods: Twenty biomarkers of innate immunity,...
2.
Dejonckheere M, Antonelli M, Arvaniti K, Blot K, CreaghBrown B, de Lange D, et al.
J Intensive Med . 2024 Jan; 4(1):81-93. PMID: 38263964
Background: The -classification defines specific phenotypes of patients with intra-abdominal infection based on the (1) setting of infection onset (community-acquired, early onset, or late-onset hospital-acquired), (2) presence or absence of...
3.
Ramasco F, Mendez R, Suarez de la Rica A, Gonzalez de Castro R, Maseda E
J Pers Med . 2024 Jan; 14(1). PMID: 38248807
The main recent change observed in the field of critical patient infection has been universal awareness of the need to make better use of antimicrobials, especially for the most serious...
4.
De Waele J, Coccolini F, Lagunes L, Maseda E, Rausei S, Rubio-Perez I, et al.
Antibiotics (Basel) . 2023 Dec; 12(12). PMID: 38136745
This comprehensive review aims to provide a practical guide for intensivists, focusing on enhancing patient care associated with nosocomial peritonitis (NP). It explores the epidemiology, diagnosis, and management of NP,...
5.
Candel F, Salavert M, Basaras M, Borges M, Canton R, Cercenado E, et al.
J Clin Med . 2023 Nov; 12(21). PMID: 37959328
Community-acquired pneumonia represents the third-highest cause of mortality in industrialized countries and the first due to infection. Although guidelines for the approach to this infection model are widely implemented in...
6.
Maseda E, Martin-Loeches I, Zaragoza R, Peman J, Fortun J, Grau S, et al.
Crit Care . 2023 Oct; 27(1):382. PMID: 37789338
Background: Regardless of the available antifungals, intraabdominal candidiasis (IAC) mortality continues to be high and represents a challenge for clinicians. Main Body: This opinion paper discusses alternative antifungal options for...
7.
Suarez-de-la-Rica A, Ripolles-Melchor J, Aldecoa C, Abad-Motos A, Ferrando C, Abad-Gurumeta A, et al.
J Gastrointest Surg . 2023 Aug; 27(10):2187-2198. PMID: 37550589
Background: The efficacy of routine admission of high-risk patients to a critical care unit after surgery is not clear. The aim of our study was to investigate the association between...
8.
Martinez-Castro S, Monleon B, Puig J, Gomez C, Quesada M, Pestana D, et al.
J Pers Med . 2023 Jun; 13(6). PMID: 37373914
Background: Acute respiratory distress syndrome (ARDS) related to COVID-19 (coronavirus disease 2019) led to intensive care units (ICUs) collapse. Amalgams of sedative agents (including volatile anesthetics) were used due to...
9.
Bermejo-Martin J, Garcia-Mateo N, Motos A, Resino S, Tamayo L, Ryan Murua P, et al.
Lancet Microbe . 2023 Apr; 4(6):e431-e441. PMID: 37116517
Background: The contribution of the virus to the pathogenesis of severe COVID-19 is still unclear. We aimed to evaluate associations between viral RNA load in plasma and host response, complications,...
10.
De Pascale G, Antonelli M, Deschepper M, Arvaniti K, Blot K, Brown B, et al.
Intensive Care Med . 2022 Sep; 48(11):1593-1606. PMID: 36151335
Purpose: To describe data on epidemiology, microbiology, clinical characteristics and outcome of adult patients admitted in the intensive care unit (ICU) with secondary peritonitis, with special emphasis on antimicrobial therapy...